Enliven Therapeutics, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Enliven Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Enliven Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $79K, a 17.9% increase year-over-year.
  • Enliven Therapeutics, Inc. annual Depreciation for 2023 was $297K, a 38.1% increase from 2022.
  • Enliven Therapeutics, Inc. annual Depreciation for 2022 was $215K, a 87% increase from 2021.
  • Enliven Therapeutics, Inc. annual Depreciation for 2021 was $115K, a 18.6% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $297K +$82K +38.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $215K +$100K +87% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $115K +$18K +18.6% Jan 1, 2021 Dec 31, 2021 8-K 2023-06-23
2020 $97K +$64K +194% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $33K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.